Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2022-08-11 4:54 pm Purchase | 13D | VERONA PHARMA PLC SPONSORED AD VRNA | Abingworth LLP | 21,313,822 4.4% | 249,600 (+1.18%) | View |
| 2022-07-11 4:30 pm Sale | 13D | SIERRA ONCOLOGY INC SRRA | Abingworth LLP | 0 0% | -2,193,626 (Position Closed) | View |
| 2022-05-13 4:31 pm Purchase | 13G | HILLEVAX INC HLVX | Abingworth LLP | 1,838,486 5.5% | 1,838,486 (New Position) | View |
| 2022-04-08 4:35 pm Purchase | 13D | SOLENO THERAPEUTICS INC NE SLNO | Abingworth LLP | 18,368,373 15.3% | 7,823,974 (+74.20%) | View |
| 2022-04-07 4:39 pm Purchase | 13D | VERA THERAPEUTICS INC VERA | Abingworth LLP | 2,970,156 11.1% | 9,925 (+0.34%) | View |
| 2022-03-21 4:52 pm Unchanged | 13D | SIERRA ONCOLOGY INC SRRA | Abingworth LLP | 2,193,626 8.9% | 0 (Unchanged) | View |
| 2022-02-25 4:15 pm Purchase | 13D | EXICURE INC XCUR | Abingworth LLP | 7,084,297 6.5% | 830,682 (+13.28%) | View |
| 2022-02-14 4:17 pm Purchase | 13G | VAXCYTE INC PCVX | Abingworth LLP | 4,183,716 7.9% | 14,998 (+0.36%) | View |
| 2022-02-10 5:00 pm Purchase | 13D | SIERRA ONCOLOGY INC SRRA | Abingworth LLP | 2,193,626 11.3% | 150,000 (+7.34%) | View |
| 2021-11-05 4:40 pm Purchase | 13D | SIERRA ONCOLOGY INC SRRA | Abingworth LLP | 2,043,626 12.6% | 7,874 (+0.39%) | View |
| 2021-10-04 4:10 pm Purchase | 13D | JASPER THERAPEUTICS INC JSPR | Abingworth LLP | 5,628,558 15.4% | 5,628,558 (New Position) | View |
| 2021-09-03 4:00 pm Purchase | 13D | EFFECTOR THERAPEUTICS INC EFTR | Abingworth LLP | 4,822,114 11.9% | 4,822,114 (New Position) | View |
| 2021-05-24 09:34 am Purchase | 13D | VERA THERAPEUTICS INC VERA | Abingworth LLP | 2,960,231 14.6% | 2,960,231 (New Position) | View |
| 2021-04-20 4:07 pm Purchase | 13D | RENEO PHARMACEUTICALS INC RPHM | Abingworth LLP | 1,858,226 7.7% | 1,858,226 (New Position) | View |
| 2021-03-16 4:18 pm Sale | 13D | ADICET BIO INC ACET | Abingworth LLP | 1,615,385 5.2% | -25,336 (-1.54%) | View |
| 2021-03-08 08:30 am Unchanged | 13D | ADICET BIO INC ACET | Abingworth LLP | 1,640,721 5.2% | 0 (Unchanged) | View |
| 2021-03-08 08:15 am Purchase | 13G | ADICET BIO INC ACET | Abingworth LLP | 1,640,721 5.2% | 1,640,721 (New Position) | View |
| 2021-02-16 4:06 pm Purchase | 13G | VAXCYTE INC PCVX | Abingworth LLP | 4,168,718 8.2% | 4,168,718 (New Position) | View |
| 2021-02-16 4:04 pm Sale | 13G | PERSONALIS INC PSNL | Abingworth LLP | 0 0% | -4,462,452 (Position Closed) | View |
| 2020-10-16 4:05 pm Purchase | 13D | SPRUCE BIOSCIENCES INC SPRB | Abingworth LLP | 1,792,518 7.7% | 1,792,518 (New Position) | View |